World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
14689
World Ranking
11275
National Ranking
4885

Michael S. Kinch publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Michael S. Kinch sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 138 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Michael S. Kinch D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael S. Kinch sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 61 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Michael S. Kinch is affiliated with Washington University in St. Louis in the United States. Their research spans multiple disciplines with a primary focus on medicine and economics, econometrics, and finance.

Their work covers significant subfields such as economics and econometrics, public health, environmental and occupational health, reproductive medicine, molecular biology, and biomedical engineering.

Kinch's research topics include pharmaceutical economics and policy, science, research, and medicine, health systems, economic evaluations, quality of life, biotechnology and related fields, health and medical research impacts, biomedical and engineering education, and vaccine coverage and hesitancy.

Frequent collaborators of Michael S. Kinch include Zachary Kraft, Tyler Schwartz, Everett G. Hall, Emre Toker, and Keith Burridge.

Kinch has published extensively in the following venues:

  • Drug Discovery Today
  • Journal of Clinical and Translational Science
  • UNC Libraries
  • "The" biomedical & life sciences collection
  • ACS Pharmacology & Translational Science

Their recent papers include:

  • Monoclonal antibodies: Trends in therapeutic success and commercial focus, 2022, Drug Discovery Today
  • Integrin-mediated cell adhesion activates mitogen-activated protein kinases., 2021, UNC Libraries
  • Expanding roles for academic entrepreneurship in drug discovery, 2020, Drug Discovery Today
  • 2021 in review: FDA approvals of new medicines, 2022, Drug Discovery Today
  • Sources of innovation for new medicines: questions of sustainability, 2020, Drug Discovery Today

Best Publications

  • Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.

    Roya Khosravi-Far;Patricia A. Solski;Geoffrey J. Clark;Michael S. Kinch

  • INTEGRIN-MEDIATED CELL ADHESION ACTIVATES MITOGEN-ACTIVATED PROTEIN KINASES

    Qiming Chen;Michael S. Kinch;Tsung H. Lin;Keith Burridge

  • An analysis of FDA-approved drugs: natural products and their derivatives.

    Eric Patridge;Peter C. Gareiss;Michael S. Kinch;Denton Hoyer

  • Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation

    Hui Miao;Elisabeth Burnett;Michael Kinch;Erin Simon

  • EphA2 overexpression causes tumorigenesis of mammary epithelial cells

    Daniel P. Zelinski;Nicole Dodge Zantek;Jane C. Stewart;Armando R. Irizarry

  • Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia

    Michael S. Kinch;Geoffrey J. Clark;Channing J Der;Keith W T Burridge

  • Molecular Regulation of Tumor Cell Vasculogenic Mimicry by Tyrosine Phosphorylation: Role of Epithelial Cell Kinase (Eck/EphA2)

    Angela R. Hess;Elisabeth A. Seftor;Lynn M. G. Gardner;Kelly Carles-Kinch

  • E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.

    Nicole Dodge Zantek;Minoudokht Azimi;Mary Fedor-Chaiken;Bingcheng Wang

  • Overexpression of the EphA2 tyrosine kinase in prostate cancer

    J. Walker-Daniels;K. Coffman;M. Azimi;J. S. Rhim

  • Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

    Michael S. Kinch;Mary-Beth Moore;David H. Harpole

  • EphA2 expression is associated with aggressive features in ovarian carcinoma

    Premal H. Thaker;Michael Deavers;Joseph Celestino;Angela Thornton

  • Antibody Targeting of the EphA2 Tyrosine Kinase Inhibits Malignant Cell Behavior

    Kelly Carles-Kinch;Katherine E Kilpatrick;Jane C Stewart;Michael S Kinch

  • An overview of FDA-approved new molecular entities: 1827–2013

    Michael S. Kinch;Austin Haynesworth;Sarah L. Kinch;Denton Hoyer

  • VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.

    Angela R Hess;Elisabeth A Seftor;Lynn M Gruman;Michael S Kinch

  • The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation

    Geoffrey J. Clark;Michael S. Kinch;Kelley Rogers-Graham;Said M. Sebti

  • Differential regulation of EphA2 in normal and malignant cells

    Jennifer Walker-Daniels;Angela R. Hess;Mary J.C. Hendrix;Michael S. Kinch

  • Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

    Michael S Kinch;Kelly Carles-Kinch

  • c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.

    Jennifer Walker-Daniels;David J. Riese;Michael S. Kinch

  • DYNAMIC INTERACTION OF PTPMU WITH MULTIPLE CADHERINS IN VIVO

    Susann M. Brady-Kalnay;Tracy Mourton;Joseph P. Nixon;Gregory E. Pietz

  • Regulation of the EphA2 Kinase by the Low Molecular Weight Tyrosine Phosphatase Induces Transformation

    Keith D. Kikawa;Derika R. Vidale;Robert L. Van Etten;Michael S. Kinch

Frequent Co-Authors

Peter A. Kiener
Peter A. Kiener AstraZeneca (United Kingdom)
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Charles N. Landen
Charles N. Landen University of Virginia
Keith Burridge
Keith Burridge University of North Carolina at Chapel Hill
Walter J. Storkus
Walter J. Storkus University of Pittsburgh
Liang Cheng
Liang Cheng Brown University
Channing J. Der
Channing J. Der University of North Carolina at Chapel Hill
Suresh K. Mittal
Suresh K. Mittal Purdue University West Lafayette
Gene G. Olinger
Gene G. Olinger Boston University
Kelly L. Warfield
Kelly L. Warfield United States Department of the Army

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Biology and Biochemistry graduates have a variety of flexible online pathways to expand their knowledge and advance their careers. Many professionals explore options like online fnp programs, which offer a streamlined route to become a Family Nurse Practitioner for those with a science background.

For those passionate about nutrition and wellness, accredited online dietetics programs allow students to transition into dietetics and nutrition consulting. If you’re already a registered nurse, consider advancing your credentials with one of the rn to bsn online programs designed for working professionals.

For those seeking leadership roles, an accelerated healthcare management degree online can help you step into supervisory positions quickly. All these flexible options can lead to rewarding roles that build on your Biology or Biochemistry foundation.

Best Scientists Citing Michael S. Kinch

Trending Scientists

Recently Published Articles